Please login to the form below

F2G

This page shows the latest F2G news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s John Rex joins UK biotech F2G

John Rex has moved from AstraZeneca to F2G to become the Manchester, UK-based drug discovery firm's chief medical officer. ... new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials.
F2G appoints chief financial officer

Ralf Schmid brings experience from Nabriva Therapeutics. Manchester-based F2G Ltd has appointed Ralf Schmid as its new chief financial officer. ... Ian Nicholson, chief executive of F2G, said: “Following our successful $60m financing, I am delighted to

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Global Business Development Director – Health Education: excellent commission

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Add my company

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

NHS regional footprints: What to expect from 2019...
Not another weight-loss ad: Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...